Table 2 Characteristics of hemodynamic drugs used in operation, side effect and postoperative follow-up
S (n = 60) | PR (n = 61) | P value | |
|---|---|---|---|
AUCcTnI-24 h (μg/ml) | 0.408[0.364,0.456] | 0.456[0.416,0.496] | 0.001 |
AUCcTnI-subtracted(μg/ml) | 0.312[0.244,0.324] | 0.376[0.324,0.412] | 0.001 |
Estimated blood loss(ml) | 520[430/587.5] | 460[395/570] | 0.015 |
Number of blood transfusion | 11(18.3) | 10(16.4) | 0.778 |
Total blood transfusion(ml) | 200[200,200] | 200[200,300] | 0.122 |
Urapidil(mg) | 30[0/40] | 20[0/40] | 0.621 |
Phenylephrine(μg) | 300[200/400] | 600[400/800] | 0.001 |
Side effect | |||
Delirium | 5(8.3) | 2(3.3) | 0.213 |
Nausea | 15(25.0) | 12(20.0) | 0.482 |
Complaint of pain after operation | 12(20.0) | 15(24.6) | 0.544 |
Postoperative 3-month follow-up | |||
Myocardial ischemiaa | 2(3.3) | 3(5.0) | 0.508 |
Supraventricular tachycardia | 0(0) | 1(1.7) | 0.504 |
All-cause mortality | 1(1.7) | 0(0) | 0.496 |